686
Views
59
CrossRef citations to date
0
Altmetric
Review

The evolving role of mass spectrometry in cancer biomarker discovery

Pages 1083-1094 | Published online: 15 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Elena Martinez-Garcia, Carlos Lopez-Gil, Irene Campoy, Julia Vallve, Eva Coll, Silvia Cabrera, Santiago Ramon Y Cajal, Xavier Matias-Guiu, Jan Van Oostrum, Jaume Reventos, Antonio Gil-Moreno & Eva Colas. (2018) Advances in endometrial cancer protein biomarkers for use in the clinic. Expert Review of Proteomics 15:1, pages 81-99.
Read now
Pedro Magalhães, Joost P. Schanstra, Emma Carrick, Harald Mischak & Petra Zürbig. (2016) Urinary biomarkers for renal tract malformations. Expert Review of Proteomics 13:12, pages 1121-1129.
Read now
Robert Harlan & Hui Zhang. (2014) Targeted proteomics: a bridge between discovery and validation. Expert Review of Proteomics 11:6, pages 657-661.
Read now
Andrew G Chambers, Andrew J Percy, Romain Simon & Christoph H Borchers. (2014) MRM for the verification of cancer biomarker proteins: recent applications to human plasma and serum. Expert Review of Proteomics 11:2, pages 137-148.
Read now

Articles from other publishers (55)

Liping Yang, Stanislau Stanisheuski, Zifeng Song, Shay Bracha & Claudia S. Maier. (2023) Top-down mass spectrometry for characterizing the low molecular weight proteome of canine osteosarcoma cell phenotypes. European Journal of Mass Spectrometry 29:5-6, pages 313-325.
Crossref
Erin E. Crotty, Ashley L. Wilson, Tom Davidson, Sophia Tahiri, Juliane Gust, Andrea M. Griesinger, Sujatha Venkataraman, Julie R. Park, Sabine Mueller, Brian R. Rood, Eugene I. Hwang, Leo D. Wang & Nicholas A. Vitanza. (2023) Cellular Therapy for Children with Central Nervous System Tumors: Mining and Mapping the Correlative Data. Current Oncology Reports 25:8, pages 847-855.
Crossref
Yiwu Yan, Su Yeon Yeon, Chen Qian, Sungyong You & Wei Yang. (2021) On the Road to Accurate Protein Biomarkers in Prostate Cancer Diagnosis and Prognosis: Current Status and Future Advances. International Journal of Molecular Sciences 22:24, pages 13537.
Crossref
Amanda Khoo, Lydia Y. Liu, Julius O. Nyalwidhe, O. John Semmes, Danny Vesprini, Michelle R. Downes, Paul C. Boutros, Stanley K. Liu & Thomas Kislinger. (2021) Proteomic discovery of non-invasive biomarkers of localized prostate cancer using mass spectrometry. Nature Reviews Urology 18:12, pages 707-724.
Crossref
Jeffrey R. Whiteaker, Kanika Sharma, Melissa A. Hoffman, Eric Kuhn, Lei Zhao, Alexandra R. Cocco, Regine M. Schoenherr, Jacob J. Kennedy, Ulianna Voytovich, Chenwei Lin, Bin Fang, Kiah Bowers, Gordon Whiteley, Simona Colantonio, William Bocik, Rhonda Roberts, Tara Hiltke, Emily Boja, Henry Rodriguez, Frank McCormick, Matthew Holderfield, Steven A. Carr, John M. Koomen & Amanda G. Paulovich. (2021) Targeted mass-spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP kinase, and AKT signaling. Cell Reports Methods 1:3, pages 100015.
Crossref
Henry Rodriguez, Jean Claude Zenklusen, Louis M. Staudt, James H. Doroshow & Douglas R. Lowy. (2021) The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment. Cell 184:7, pages 1661-1670.
Crossref
Bing Zhang, Jeffrey R. Whiteaker, Andrew N. Hoofnagle, Geoffrey S. Baird, Karin D. Rodland & Amanda G. Paulovich. (2018) Clinical potential of mass spectrometry-based proteogenomics. Nature Reviews Clinical Oncology 16:4, pages 256-268.
Crossref
Eleonora Orlando & Ruedi Aebersold. (2019) On the contribution of mass spectrometry-based platforms to the field of personalized oncology. TrAC Trends in Analytical Chemistry 110, pages 129-142.
Crossref
Giuseppe Latini, Claudio De Felice, Alessandro Barducci, Lucia Dipaola, Mattia Gentile, Maria Grazia Andreassi, Mario Correale & Giorgio Bianciardi. (2018) Clinical biomarkers for cancer recognition and prevention: A novel approach with optical measurements. Cancer Biomarkers 22:2, pages 179-198.
Crossref
Mariya Mardamshina & Tamar Geiger. (2017) Next-Generation Proteomics and Its Application to Clinical Breast Cancer Research. The American Journal of Pathology 187:10, pages 2175-2184.
Crossref
Ehwang Song, Yuqian Gao, Chaochao Wu, Tujin Shi, Song Nie, Thomas L. Fillmore, Athena A. Schepmoes, Marina A. Gritsenko, Wei-Jun Qian, Richard D. Smith, Karin D. Rodland & Tao Liu. (2017) Targeted proteomic assays for quantitation of proteins identified by proteogenomic analysis of ovarian cancer. Scientific Data 4:1.
Crossref
Björn L. D. M. Brücher, Yan Li, Philipp Schnabel, Martin Daumer, Timothy J. Wallace, Rainer Kube, Bruno Zilberstein, Scott Steele, Jan L. A. Voskuil & Ijaz S. Jamall. (2016) Genomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response in upper GI cancers. Clinical and Translational Medicine 5:1.
Crossref
Tommaso De Marchi, Erik Kuhn, Lennard J. Dekker, Christoph Stingl, Rene B. H. Braakman, Mark Opdam, Sabine C. Linn, Fred C. G. J. Sweep, Paul N. Span, Theo M. Luider, John A. Foekens, John W. M. Martens, Steven A. Carr & Arzu Umar. (2016) Targeted MS Assay Predicting Tamoxifen Resistance in Estrogen-Receptor-Positive Breast Cancer Tissues and Sera. Journal of Proteome Research 15:4, pages 1230-1242.
Crossref
Parul Mittal, Manuela Klingler-Hoffmann, Georgia Arentz, Chao Zhang, Gurjeet Kaur, Martin K. Oehler & Peter Hoffmann. (2016) Proteomics of endometrial cancer diagnosis, treatment, and prognosis. PROTEOMICS - Clinical Applications 10:3, pages 217-229.
Crossref
Minhyung KimDaehee Hwang. (2016) Network-Based Protein Biomarker Discovery Platforms. Genomics & Informatics 14:1, pages 2.
Crossref
Shiying Shao, Tiannan Guo & Ruedi Aebersold. (2015) Mass spectrometry-based proteomic quest for diabetes biomarkers. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1854:6, pages 519-527.
Crossref
Gilles Schnell, Amandine Boeuf, Benoît Westermann, Benoît Jaulhac, Dan Lipsker, Christine Carapito, Nathalie Boulanger & Laurence Ehret-Sabatier. (2015) Discovery and Targeted Proteomics on Cutaneous Biopsies Infected by Borrelia to Investigate Lyme Disease*. Molecular & Cellular Proteomics 14:5, pages 1254-1264.
Crossref
Regine M. Schoenherr, Richard G. Saul, Jeffrey R. Whiteaker, Ping Yan, Gordon R. Whiteley & Amanda G. Paulovich. (2015) Anti-Peptide Monoclonal Antibodies Generated for Immuno-Multiple Reaction Monitoring-Mass Spectrometry Assays Have a High Probability of Supporting Western blot and ELISA. Molecular & Cellular Proteomics 14:2, pages 382-398.
Crossref
Zane Kalniņa. (2015) Emerging blood-based biomarkers for detection of gastric cancer. World Journal of Gastroenterology 21:41, pages 11636.
Crossref
Hangyeore Lee, Dong-Gi Mun, Jingi Bae, Hokeun Kim, Se Yeon Oh, Young Soo Park, Jae-Hyuk Lee & Sang-Won Lee. (2015) A simple dual online ultra-high pressure liquid chromatography system (sDO-UHPLC) for high throughput proteome analysis. The Analyst 140:16, pages 5700-5706.
Crossref
Emily S. Boja, Thomas E. Fehniger, Mark S. Baker, György Marko-Varga & Henry Rodriguez. (2014) Analytical Validation Considerations of Multiplex Mass-Spectrometry-Based Proteomic Platforms for Measuring Protein Biomarkers. Journal of Proteome Research 13:12, pages 5325-5332.
Crossref
Carol E. Parker & Christoph H. Borchers. (2014) Mass spectrometry based biomarker discovery, verification, and validation — Quality assurance and control of protein biomarker assays. Molecular Oncology 8:4, pages 840-858.
Crossref
Shengtao Zhou, Rui Liu, Kefei Yuan, Tao Yi, Xia Zhao, Canhua Huang & Yuquan Wei. (2012) Proteomics analysis of tumor microenvironment: Implications of metabolic and oxidative stresses in tumorigenesis. Mass Spectrometry Reviews 32:4, pages 267-311.
Crossref
Maria P. Pavlou, Ivan M. Blasutig & Eleftherios P. Diamandis. 2013. Comprehensive Biomarker Discovery and Validation for Clinical Application. Comprehensive Biomarker Discovery and Validation for Clinical Application 334 352 .
J. Lemarié & S. Gibot. (2013) Combinaison de biomarqueurs pour le diagnostic du sepsis en réanimationCombining biomarkers to improve sepsis diagnosis in the intensive care unit. Réanimation 22:3, pages 306-313.
Crossref
Maria P Pavlou, Eleftherios P Diamandis & Ivan M Blasutig. (2013) The Long Journey of Cancer Biomarkers from the Bench to the Clinic. Clinical Chemistry 59:1, pages 147-157.
Crossref
Maria P. Pavlou & Eleftherios P. Diamandis. 2013. Genomic and Personalized Medicine. Genomic and Personalized Medicine 263 271 .
Elena Lopez Villar & William Chi-Shing Cho. 2013. Bioinformatics of Human Proteomics. Bioinformatics of Human Proteomics 75 101 .
Elena López, Sarbelio Rodríguez Muñoz, Juan López Pascual & Luis Madero. (2012) Relevant phosphoproteomic and mass spectrometry: approaches useful in clinical research. Clinical and Translational Medicine 1:1.
Crossref
Elena López, Luis Madero, Juan López-Pascual & Martin Latterich. (2012) Clinical proteomics and OMICS clues useful in translational medicine research. Proteome Science 10:1.
Crossref
Chi-Hsien Chou, Lea-Yea Chuang, Wei-Lung Tseng & Chi-Yu Lu. (2012) Characterization of protein adducts formed by toxic alkaloids by nano-scale liquid chromatography with mass spectrometry. Journal of Mass Spectrometry 47:10, pages 1303-1312.
Crossref
Xiaoxue Zhang, Zhaolin Yuan, Bo Shen, Min Zhu, Chibo Liu & Wei Xu. (2011) Discovery of serum protein biomarkers in rheumatoid arthritis using MALDI-TOF-MS combined with magnetic beads. Clinical and Experimental Medicine 12:3, pages 145-151.
Crossref
Alexander Benedikt Leichtle, Jean-Marc Nuoffer, Uta Ceglarek, Julia Kase, Tim Conrad, Helmut Witzigmann, Joachim Thiery & Georg Martin Fiedler. (2011) Serum amino acid profiles and their alterations in colorectal cancer. Metabolomics 8:4, pages 643-653.
Crossref
Paola Picotti & Ruedi Aebersold. (2012) Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions. Nature Methods 9:6, pages 555-566.
Crossref
Mustafa Kemal Sezgintürk & Zihni Onur Uygun. (2012) An impedimetric vascular endothelial growth factor biosensor-based PAMAM/cysteamine-modified gold electrode for monitoring of tumor growth. Analytical Biochemistry 423:2, pages 277-285.
Crossref
Tujin Shi, Dian Su, Tao Liu, Keqi Tang, David G. CampIIII, Wei‐Jun Qian & Richard D. Smith. (2012) Advancing the sensitivity of selected reaction monitoring‐based targeted quantitative proteomics. PROTEOMICS 12:8, pages 1074-1092.
Crossref
Emily S. Boja & Henry Rodriguez. (2012) Mass spectrometry‐based targeted quantitative proteomics: Achieving sensitive and reproducible detection of proteins. PROTEOMICS 12:8, pages 1093-1110.
Crossref
Courtney J. Doyle, Kyle Yancey, Henry A. Pitt, Mu Wang, Kerry Bemis, Michele T. Yip-Schneider, Stuart T. Sherman, Keith D. Lillemoe, Michael D. Goggins & C. Max Schmidt. (2012) The Proteome of Normal Pancreatic Juice. Pancreas 41:2, pages 186-194.
Crossref
Christoph Krisp, Matthew J. McKay, Dirk A. Wolters & Mark P. Molloy. (2012) Multidimensional Protein Identification Technology-Selected Reaction Monitoring Improving Detection and Quantification for Protein Biomarker Studies. Analytical Chemistry 84:3, pages 1592-1600.
Crossref
Manfred Rauh. (2012) LC–MS/MS for protein and peptide quantification in clinical chemistry. Journal of Chromatography B 883-884, pages 59-67.
Crossref
Obi L Griffith & Joe W Gray. (2011) 'Omic approaches to preventing or managing metastatic breast cancer. Breast Cancer Research 13:6.
Crossref
Chia-Jung Yu, Kai-Ping Chang, Yin-Ju Chang, Chia-Wei Hsu, Ying Liang, Jau-Song Yu, Lang-Ming Chi, Yu-Sun Chang & Chih-Ching Wu. (2011) Identification of Guanylate-Binding Protein 1 as a Potential Oral Cancer Marker Involved in Cell Invasion Using Omics-Based Analysis. Journal of Proteome Research 10:8, pages 3778-3788.
Crossref
Jeffrey R Whiteaker, Chenwei Lin, Jacob Kennedy, Liming Hou, Mary Trute, Izabela Sokal, Ping Yan, Regine M Schoenherr, Lei Zhao, Uliana J Voytovich, Karen S Kelly-Spratt, Alexei Krasnoselsky, Philip R Gafken, Jason M Hogan, Lisa A Jones, Pei Wang, Lynn Amon, Lewis A Chodosh, Peter S Nelson, Martin W McIntosh, Christopher J Kemp & Amanda G Paulovich. (2011) A targeted proteomics–based pipeline for verification of biomarkers in plasma. Nature Biotechnology 29:7, pages 625-634.
Crossref
Mustafa Kemal Sezgintürk. (2011) A new impedimetric biosensor utilizing VEGF receptor-1 (Flt-1): Early diagnosis of vascular endothelial growth factor in breast cancer. Biosensors and Bioelectronics 26:10, pages 4032-4039.
Crossref
Emily S. Boja & Henry Rodriguez. (2011) The Path to Clinical Proteomics Research: Integration of Proteomics, Genomics, Clinical Laboratory and Regulatory Science. Annals of Laboratory Medicine 31:2, pages 61-71.
Crossref
Emily S Boja, Saeed A Jortani, James Ritchie, Andrew N Hoofnagle, Živana Težak, Elizabeth Mansfield, Penny Keller, Robert C Rivers, Amir Rahbar, N Leigh Anderson, Pothur Srinivas & Henry Rodriguez. (2011) The Journey to Regulation of Protein-Based Multiplex Quantitative Assays. Clinical Chemistry 57:4, pages 560-567.
Crossref
A.C. Kroksveen, J.A. Opsahl, T.T. Aye, R.J. Ulvik & F.S. Berven. (2011) Proteomics of human cerebrospinal fluid: Discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics. Journal of Proteomics 74:4, pages 371-388.
Crossref
Brian Casserly, Richard Read & Mitchell M. Levy. (2011) Multimarker Panels in Sepsis. Critical Care Clinics 27:2, pages 391-405.
Crossref
Sarah Elschenbroich & Thomas Kislinger. (2011) Targeted proteomics by selected reaction monitoring mass spectrometry: applications to systems biology and biomarker discovery. Mol. BioSyst. 7:2, pages 292-303.
Crossref
Chia-Hsien Feng & Chi-Yu Lu. (2011) Modification of major plasma proteins by acrylamide and glycidamide: Preliminary screening by nano liquid chromatography with tandem mass spectrometry. Analytica Chimica Acta 684:1-2, pages 89-95.
Crossref
M. Montagnana, E. Danese, S. Giudici, M. Franchi, G.C. Guidi, M. Plebani & G. Lippi. 2011. 1 20 .
Emily Boja, Robert Rivers, Christopher Kinsinger, Mehdi Mesri, Tara Hiltke, Amir Rahbar & Henry Rodriguez. (2010) Restructuring proteomics through verification. Biomarkers in Medicine 4:6, pages 799-803.
Crossref
Henry Rodriguez, Robert Rivers, Christopher Kinsinger, Mehdi Mesri, Tara Hiltke, Amir Rahbar & Emily Boja. (2010) Reconstructing the pipeline by introducing multiplexed multiple reaction monitoring mass spectrometry for cancer biomarker verification: An NCI-CPTC initiative perspective. PROTEOMICS - Clinical Applications 4:12, pages 904-914.
Crossref
A. Blokzijl, M. Friedman, F. Pontén & U. Landegren. (2010) Profiling protein expression and interactions: proximity ligation as a tool for personalized medicine. Journal of Internal Medicine 268:3, pages 232-245.
Crossref
David Arnott & Michael R Emmert-Buck. (2010) Proteomic profiling of cancer-opportunities, challenges, and context. The Journal of Pathology 222:1, pages 16-20.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.